You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recurrent Non-small Cell Lung Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    Apr 21, 2023

    Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (Chemotherapy, Pembrolizumab, Ramucirumab)

    Not yet recruiting
    • Recurrent Lung Non-Small Cell Carcinoma
    • Stage IV Lung Cancer AJCC v8
    • (no location specified)
    Jan 9, 2023

    Non Small Cell Lung Cancer, Metastatic NSCLC, Recurrent Non Small Cell Lung Cancer Trial (Pembrolizumab, GT103)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • +2 more
    • (no location specified)
    Jan 12, 2023

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Seattle

    Not yet recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +2 more
    • Atezolizumab
    • +6 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 6, 2023

    Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)

    Not yet recruiting
    • Recurrent Lung Non-Small Cell Carcinoma
    • Stage IV Lung Cancer AJCC v8
    • Biospecimen Collection
    • +5 more
    • (no location specified)
    Sep 7, 2023

    Lung Non-Small Cell Carcinoma Trial (Amivantamab, Biospecimen Collection, Computed Tomography)

    Not yet recruiting
    • Lung Non-Small Cell Carcinoma
    • Amivantamab
    • +3 more
    • (no location specified)
    Oct 30, 2023

    NSCLC, NSCLC Stage III, Recurrent Non Small Cell Lung Cancer Trial (Garmin Vivofit Activity Tracker)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +2 more
    • Garmin Vivofit Activity Tracker
    • (no location specified)
    Aug 31, 2022

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in

    Recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +3 more
    • Biopsy
    • +6 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 9, 2023

    Extensive Stage Small Cell Lung Carcinoma, Lung Adenocarcinoma, Recurrent Non-Small Cell Lung Carcinoma Trial in Scottsdale,

    Recruiting
    • Extensive Stage Small Cell Lung Carcinoma
    • +7 more
    • Scottsdale, Arizona
    • +1 more
    Jun 27, 2022

    Non Small Cell Lung Cancer, Stage IV NSCLC, Recurrent Non Small Cell Lung Cancer Trial in Tampa (biological, drug, other)

    Recruiting
    • Non Small Cell Lung Cancer
    • +2 more
    • Tumor-infiltrating Lymphocytes (TIL)
    • +5 more
    • Tampa, Florida
      Moffitt Cancer Center
    Dec 28, 2022

    NSCLC Trial in Worldwide (BMS-986315, Nivolumab, Pemetrexed)

    Not yet recruiting
    • NSCLC
    • Boise, Idaho
    • +12 more
    Oct 17, 2023

    Recurrent NSCLC, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Buffalo (therapeutic lymphadenectomy (TEMLA) and Stereotactic Body

    Completed
    • Recurrent Non-small Cell Lung Cancer
    • +3 more
    • therapeutic lymphadenectomy (TEMLA) and Stereotactic Body radiation therapy (SBRT)
    • quality-of-life assessment
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 20, 2022

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

    Not yet recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +2 more
    • Cetuximab
    • +2 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Oct 2, 2023

    Recurrent NSCLC Trial in Changchun, Shanghai (Cisplatin, Carboplatin, Docetaxel)

    Recruiting
    • Recurrent Non-small Cell Lung Cancer
    • Changchun, Jilin, China
    • +2 more
    May 3, 2022

    NSCLC Trial in Seoul (Lazertinib/Pemetrexed/Carboplatin)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Mar 23, 2023

    Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, drug, biological)

    Not yet recruiting
    • Recurrent Lung Non-Small Cell Carcinoma
    • Stage IV Lung Cancer AJCC v8
    • Biospecimen Collection
    • +5 more
    • (no location specified)
    Nov 30, 2022

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7

    Active, not recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +2 more
    • Duarte, California
    • +14 more
    Jan 27, 2023

    Metastatic Non-Small Lung Cell Cancer, Recurrent Non-Small Lung Cell Cancer, Stage IV Lung Cancer AJCC v8 Trial in Atlanta

    Recruiting
    • Metastatic Non-Small Lung Cell Cancer
    • +4 more
    • Atlanta, Georgia
      Winship Cancer Institute of Emory University
    Oct 19, 2022

    Lung Cancer Trial in Cleveland, Mayfield Heights (bevacizumab, docetaxel, gemcitabine HCl)

    Completed
    Has Results
    • Lung Cancer
    • bevacizumab
    • +2 more
    • Cleveland, Ohio
    • +3 more
    Jul 22, 2022

    Recurrent NSCLC, Stage IV NSCLC Trial in Bay City, Detroit, Port Huron (cytology specimen collection procedure, laboratory

    Recruiting
    • Recurrent Non-small Cell Lung Cancer
    • Stage IV Non-small Cell Lung Cancer
    • cytology specimen collection procedure
    • laboratory biomarker analysis
    • Bay City, Michigan
    • +2 more
    Apr 6, 2022

    Lung Atypical Carcinoid Tumor, Lung Neuroendocrine Tumor, Lung Non-Small Cell Squamous Carcinoma Trial in Conroe, Houston

    Recruiting
    • Lung Atypical Carcinoid Tumor
    • +13 more
    • Nivolumab
    • Stereotactic Body Radiation Therapy
    • Conroe, Texas
    • +2 more
    Feb 25, 2022

    NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +32 more
    • (no location specified)
    Mar 30, 2023

    First-Line Nivolumab Plus Ipilimumab With or Without

    Recruiting
    • Non-Small Cell Lung Cancer
      • Minato-ku, Tokyo, Japan
        Local Institution
      Dec 6, 2021

      Non Small Cell Lung Cancer Recurrent Trial (Toripalimab, Anlotinib and Chemotherapy)

      Not yet recruiting
      • Non Small Cell Lung Cancer Recurrent
      • Toripalimab, Anlotinib and Chemotherapy
      • (no location specified)
      Apr 24, 2023

      Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

      Recruiting
      • Metastatic Lung Non-Small Cell Carcinoma
      • +4 more
      • Adenosine A2B Receptor Antagonist PBF-1129
      • +2 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Feb 1, 2023